(June 30, 2020, 2:23 PM EDT) -- CAMDEN, N.J. — A New Jersey federal judge on June 29 denied motions by six defendants to dismiss as preempted a plaintiff’s claims that she was injured by gadolinium-based contrast agents (GBCAs) (Kimberly Gremo v. Bayer Corporation, et al., No. 19-13432, D. N.J.)....